Douglas Carl Fisher
CIK 1572355 · President · last filed 2024-02-16
Douglas Carl Fisher is a President who has filed 19 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for PBAXW, was dated Feb 16, 2024. Current disclosed insider exposure totals $126.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$126.3K
4
19
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | President | 43,300 | $0.05 | $2.2K | $0 | 1 | 2024-02-16 |
| PRPO | Director | 5,572 | $22.67 | $126.3K | $0 | 11 | 2023-10-31 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | President | 10,000 | $10.37 | $103.7K | $0 | 1 | 2021-10-12 |
| Vyome Holdings, Inc (OBLN) Delisted | Director | 26,042 | $9.15 | $238.3K | $0 | 6 | 2020-09-18 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-16 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Mixed | +43,300 | $0 | EDGAR |
| 2023-10-31 | PRPO | Grant (A) | +5,174 | $0 | EDGAR |
| 2023-09-14 | PRPO | Grant (A) | +7,954 | $0 | EDGAR |
| 2023-01-10 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2022-01-13 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2021-10-12 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Other (J) | +10,000 | $0 | EDGAR |
| 2021-08-05 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2020-09-18 | Vyome Holdings, Inc (OBLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | PRPO | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.